Abstract:Background: X-linked Alport syndrome is caused by mutations in the COL4A5 gene, which encodes the a5(IV) chain. No mutations were detected in COL4A5 exons 41A and 41B. Materials and Methods: A Chinese family with suspected Alport syndrome was enrolled in the present study to establish a precise diagnosis. The proband's father and uncle progressed to end-stage renal failure at different age. The indirect immunofluorescence method was used for analysis of distribution of a1 (IV) and a5 (IV) chains in the epidermal basement membrane from the father of the proband. The entire coding region of COL4A5 mRNA from the proband's father cultured skin fibroblasts was analyzed by using reverse-transcription polymerase chain reaction (RT-PCR) and direct sequencing, and genomic DNA was analyzed by using PCR and direct sequencing. To examine whether the alternatively COL4A5 mRNA transcripts existed in cultured skin fibroblasts, a fragment of COL4A5 cDNA, including exons 41A, 41B, and partial sequences of exons 41 and 42 was analyzed by RT-PCR and GeneScan. Results: Negative a5(IV) chain staining in the epidermal basement membrane was detected in the female proband's father who presented with hematuria, proteinuria, and renal dysfunction. Sequencing analysis demonstrated that the proband's father had a novel variant c.3791G>A [p. (Gly1264Asp)] in COL4A5 exon 41A detected at the mRNA and genomic DNA levels, and the variant segregated with disease in the family. According to the phenotype and American College of Medical Genetics and Genomics guideline, this variant was considered clinically pathogenic. The GeneScan analysis showed three COL4A5 mRNA transcripts expressed in the cultured skin fibroblasts of the proband's father and two normal males, and variation could be seen in the amounts of amplified isoforms. Conclusions: A glycine substitution in COL4A5 exon 41A was identified in a family with intrafamilial heterogeneity of the rate of progression to end-stage renal failure in male patients, which extends the phenotypic and mutational spectrum of X-linked Alport syndrome. In addition, skin tissue has three distinct COL4A5 transcripts with a diversity of expression.

Characterization of the genotype in Alport syndrome with diffuse leiomyomatosis

Clinical Manifestations of Alport Syndrome-Diffuse Leiomyomatosis Patients With Contiguous Gene Deletions in COL4A6 and COL4A5

Features of Phenotype and Genotype in Chinese Alport Syndrome Patients

Novel Mutations In Col4a3, Col4a4, And Col4a5 In Chinese Patients With Alport Syndrome

Phenotypic and genotypic features of Alport syndrome in Chinese children

[Features of Clinical Phenotype and Genotype in Alport Syndrome: a Monocentric Study].

Detection of a Novel Mutation in COL4A5 Gene from a Chinese Family with X-linked Alport Syndrome

Relationship Between Genotype and Phenotype in Alport Syndrome: Analysis at Α5 (IV) Chain Mrna Level

Prenatal Diagnosis And Genetic Counseling Of A Chinese Alport Syndrome Kindred

A Novel COL4A5 Splicing Mutation Causes Skipping of Exon 14 in a Chinese Family with Alport Syndrome

The First COL4A5 Exon 41A Glycine Substitution in a Family with Alport Syndrome

Comparative Functional Analysis in Vitro of 2 COL4A5 Splicing Mutations at the Same Site in 2 Unrelated Alport Syndrome Chinese Families.

Genetic diagnosis of Alport syndrome in 16 Chinese families

Dyspnea and nocturnal cough due to esophageal diffuse leiomyomatosis in a girl with hematuria

Study of gene mutation in one pedigree with X-linked dominant inherited Alport's syndrome

A Novel Splicing Mutation Identified in a Chinese Family with X-linked Alport Syndrome Using Targeted Next-Generation Sequencing.

Identification of a Novel COL4A5 Mutation in the Proband Initially Diagnosed As IgAN from a Chinese Family with X-linked Alport Syndrome.

A Novel Missense Mutation of COL4A5 Gene Alter Collagen IV Α5 Chain to Cause X-linked Alport Syndrome in a Chinese Family.

Correlation Between Mrna Expression Level of the Mutant COL4A5 Gene and Phenotypes of XLAS Females.

A Novel Mutation of COL4A3 Presents a Different Contribution to Alport Syndrome and Thin Basement Membrane Nephropathy

Detection of COL4A5 gene mutations in Alport syndrome by analyzing cDNA of skin fibroblasts